United States Arthropod Borne Viral Infections Testing Market 2025 | RT-PCR-based tests dominate with 52% share due to high sensitivity, rapid detection, and widespread use for dengue

Leander, Texas and Tokyo, Japan - Dec.03.2025
As per DataM intelligence research report" Arthropod borne Viral Infections Testing market size is growing at a high CAGR during the forecast period (2022-2029)" Rising outbreaks and vector-borne disease surveillance efforts are accelerating demand for advanced diagnostic testing.

Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/arthropod-borne-viral-infections-testing-market?Prasad

United States: Recent Industry Developments

✅ In 2025, Abbott introduced a new rapid diagnostic test that detects Zika, dengue, and chikungunya in a single assay The 3-in-1 test significantly reduces turnaround time for diagnosing travel-related fevers It is now widely used in U.S. clinics for emergency outbreak response

✅ In October 2025, The FDA issued Emergency Use Authorization for a new molecular test for Oropouche virus The authorization follows a rise in imported cases and enables U.S. labs to detect the virus quickly It strengthens the U.S. biodefense capability against emerging arboviral threats

✅ In August 2025, Thermo Fisher Scientific launched a field-deployable real-time PCR kit for West Nile Virus The kit is battery-operated and delivers results in under 25 minutes for mosquito pool testing It empowers U.S. vector control districts with rapid surveillance data

✅ In May 2025, Quest Diagnostics expanded its arbovirus test menu to include a new panel for tick-borne Powassan virus The panel addresses the increasing incidence of rare tick-borne diseases in the Northeast U.S. It provides comprehensive diagnostic options for patients with unexplained encephalitis

Japan: Recent Industry Developments

✅ In November 2025, Roche Diagnostics Japan launched an upgraded high-throughput Cobas system for blood screening The system includes improved sensitivity for detecting dengue and Zika virus in donor blood. It ensures the safety of Japan's blood supply against imported arboviruses

✅ In September 2025, The National Institute of Infectious Diseases (NIID) validated a new rapid test kit for Japanese Encephalitis The kit allows for point-of-care diagnosis in rural clinics without sending samples to central labs It improves early detection and management of encephalitis cases in Japan

✅ In July 2025, QIAGEN introduced a digital PCR-based arbovirus panel to Japanese public health labs The panel offers a 44% improvement in diagnostic accuracy over standard tests It enhances the surveillance capability for vector-borne diseases across Japan

✅ In April 2025, The MHLW approved the first commercial PCR kit specifically for Severe Fever with Thrombocytopenia Syndrome (SFTS) The approval standardizes the testing for this tick-borne virus which is endemic to parts of Japan It aids Japanese doctors in rapidly diagnosing this potentially fatal condition

Arthropod borne Viral Infections Testing Market: Drivers
The arthropod-borne viral infections testing market is growing as public health agencies respond to rising cases of mosquito- and tick-borne diseases such as dengue, Zika, chikungunya, and West Nile virus. Early detection and rapid diagnostic testing are essential for outbreak management and disease surveillance. Advancements in molecular diagnostics, serology, and point-of-care testing are improving accuracy and turnaround time. Increasing global travel, climate change, and urbanization are expanding disease transmission zones, driving testing demand. Additionally, government-led surveillance programs are strengthening market growth.

Collaboration among diagnostic companies, research institutions, and public health agencies is accelerating development of rapid, multiplex, and high-sensitivity testing platforms. Growth in portable diagnostics, community health programs, and telehealth-enabled lab services is improving accessibility. Integration of digital reporting, AI-based detection models, and epidemiological analytics is enhancing disease monitoring. With rising infectious disease threats and innovation in diagnostics, the arthropod-borne viral infections testing market is poised for strong growth.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/arthropod-borne-viral-infections-testing-market?Prasad

Arthropod borne Viral Infections Testing Market: Major Players
Bio-Techne, Agilent Technologies, ThermoFisher Scientific, NovaTec Immundiagnostica, Euro immune AG, Abbott Laboratories, Bio-Rad, Merck, Acrobiosystems, Elabscience among others.

Segment Covered in the Arthropod borne Viral Infections Testing Market:
By Test Type
RT-PCR-based tests dominate with 52% share due to high sensitivity, rapid detection, and widespread use for dengue, Zika, and West Nile virus confirmation. ELISA-based tests hold 38%, driven by affordability and suitability for large-scale serological screening. Other methods account for 10%, including rapid antigen tests and next-generation sequencing used in specialized labs.

By Disease Type
Dengue leads with 34% share owing to high global case volumes, especially in Asia and Latin America. Zika accounts for 18% due to ongoing surveillance needs. West Nile holds 14%, mainly driven by testing demand in North America and Europe. Chikungunya captures 12%, while yellow fever, encephalitis variants (California, Eastern Equine, St. Louis), and Powassan collectively represent 22%, driven by periodic outbreaks and regional monitoring programs.

By End-Users
Hospitals dominate with 41% share due to high patient inflow and immediate diagnostic requirements. Diagnostic centers hold 33%, supported by rising outsourced testing and advanced molecular labs. Research centers account for 16%, driven by pathogen studies and surveillance programs. Other end-users contribute 10%, including public health agencies and travel health clinics.

Regional Analysis
Asia Pacific - 42%
Asia Pacific leads with 42% share, driven by high dengue and chikungunya prevalence and expanding molecular testing infrastructure.

North America - 22%
North America holds 22%, supported by West Nile surveillance, Powassan virus testing, and advanced molecular labs.

Europe - 18%
Europe accounts for 18%, with demand driven by travel-related infections, West Nile outbreaks, and routine monitoring.

South America - 12%
South America holds 12%, driven by high dengue burden and increasing investment in public diagnostic systems.

Middle East & Africa - 6%
MEA contributes 6%, supported by yellow fever monitoring, vector-borne disease programs, and improving lab capacity.

Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=arthropod-borne-viral-infections-testing-market
(Purchase 2 or more Repots and get 50% Discount)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?Prasad

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.